Carol Wrenn

Carol Wrenn discloses dealings in 3 companies, chiefly Alpharma Inc, Heska Corp and Phibro Animal Health Corp. Over a trading history stretching from 27 January 2006 to 3 May 2018, the count stands at 51 filings.

On the open market, the record shows 3 purchases worth €38k and 24 sales worth €2.7M. On balance, insiders were net sellers of €2.6M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 11 share grants and 10 option exercises.

In size, the median ticket on the buying side is €12k.

Most recently, on 7 May 2018, the filings show a share grant in Heska Corp. The clock since the last published purchase (16 April 2014) now reads 4,574 days. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.